Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1981 Oct;46(1):70–76.

Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.

M Baron, E C Keystone, D D Gladman, P Lee, L Poplonski
PMCID: PMC1536331  PMID: 6978216

Abstract

T lymphocyte subpopulations were studied in 40 patients with scleroderma (PSS), 26 of whom were studied simultaneously for lymphoproliferative responses to phytohaemagglutinin (PHA), concanavalin A (Con A) and pokeweed mitogen (PWM). PSS patients exhibited a reduction relative to 42 age- and sex-matched controls in the absolute number and percentage of early E rosettes, late E rosettes and E rosettes formed with aminoethylisothiouronium bromide (AET) treated sheep red blood cells. There was no difference between patients and controls in the proportions of B lymphocytes. PSS patients exhibited normal lymphocyte transformation responses to PHA and ConA and an augmented response to PWM. The mitogen responses did not correlate with the absolute number or percentage of lymphocytes or T and B lymphocyte subpopulations. No correlation was observed between any immunological variable studied and the extent of skin or organ involvement, disease duration or therapy.

Full text

PDF
70

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carapeto F. J., Winkelmann R. K. Peripheral blood lymphocyte distribution in scleroderma. Dermatologica. 1975;151(4):228–235. doi: 10.1159/000251340. [DOI] [PubMed] [Google Scholar]
  2. Currie S., Saunders M., Knowles M. Immunological aspects of systemic sclerosis in vitro activity of lymphocytes from patients with the disorder. Br J Dermatol. 1971 May;84(5):400–409. doi: 10.1111/j.1365-2133.1971.tb02523.x. [DOI] [PubMed] [Google Scholar]
  3. Fleischmajer R., Perlish J. S., Reeves J. R. Cellular infiltrates in scleroderma skin. Arthritis Rheum. 1977 May;20(4):975–984. doi: 10.1002/art.1780200410. [DOI] [PubMed] [Google Scholar]
  4. Gupta S., Malaviya A. N., Rajagopalan P., Good R. A. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis. Clin Exp Immunol. 1979 Nov;38(2):342–347. [PMC free article] [PubMed] [Google Scholar]
  5. Horwitz D. A., Garrett M. A. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin Exp Immunol. 1977 Jan;27(1):92–99. [PMC free article] [PubMed] [Google Scholar]
  6. Horwitz D. A., Juul-Nielsen K. Human blood L lymphocytes in patients with active systemic lupus erythematosus, rheumatoid arthritis and scleroderma: a comparison with T and B cells. Clin Exp Immunol. 1977 Dec;30(3):370–378. [PMC free article] [PubMed] [Google Scholar]
  7. Hughes P., Holt S., Rowell N. R., Allonby I. D., Janis K., Dodd J. K. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis. Clin Exp Immunol. 1977 May;28(2):233–240. [PMC free article] [PubMed] [Google Scholar]
  8. Hughes P., Holt S., Rowell N. R., Dodd J. Thymus-dependent (T) lymphocyte deficiency in progressive systemic sclerosis. Br J Dermatol. 1976 Nov;95(5):469–473. doi: 10.1111/j.1365-2133.1976.tb00855.x. [DOI] [PubMed] [Google Scholar]
  9. Hughes P., Holt S., Rowell N. R. Leukocyte migration inhibition in progressive systemic sclerosis. Br J Dermatol. 1974 Jul;91(1):1–6. doi: 10.1111/j.1365-2133.1974.tb06709.x. [DOI] [PubMed] [Google Scholar]
  10. Johnson R. L., Ziff M. Lymphokine stimulation of collagen accumulation. J Clin Invest. 1976 Jul;58(1):240–252. doi: 10.1172/JCI108455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kondo H., Rabin B. S., Rodnan G. P. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma). J Clin Invest. 1976 Dec;58(6):1388–1394. doi: 10.1172/JCI108594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lockshin M. D., Eisenhauer A. C., Kohn R., Weksler M., Block S., Mushlin S. B. Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum. 1975 May-Jun;18(3):245–250. doi: 10.1002/art.1780180308. [DOI] [PubMed] [Google Scholar]
  13. Salem N. B., Morse J. H. Lymphocyte response to mitogens in progressive systemic sclerosis. Arthritis Rheum. 1976 Sep-Oct;19(5):875–882. doi: 10.1002/art.1780190507. [DOI] [PubMed] [Google Scholar]
  14. Stuart J. M., Postlethwaite A. E., Kang A. H. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. J Lab Clin Med. 1976 Oct;88(4):601–607. [PubMed] [Google Scholar]
  15. Winkelstein A., Rodnan G. P., Heilman J. D. Cellular immunity in progressive systemic sclerosis (scleroderma). Ann Rheum Dis. 1972 Mar;31(2):126–128. doi: 10.1136/ard.31.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Jesus D. G., Clancy R. L. Circulating T and B lymphocytes in progressive systemic sclerosis. J Rheumatol. 1975 Sep;2(3):336–339. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES